These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
253 related items for PubMed ID: 23978143
21. Botulinum A toxin injection for restrictive myopathy of thyroid-related orbitopathy: effects on intraocular pressure. Kikkawa DO, Cruz RC, Christian WK, Rikkers S, Weinreb RN, Levi L, Granet DB. Am J Ophthalmol; 2003 Apr; 135(4):427-31. PubMed ID: 12654356 [Abstract] [Full Text] [Related]
22. A review of 5 years' experience in the use of botulinium toxin A in the treatment of sixth cranial nerve palsy at the Singapore National Eye Centre. Quah BL, Ling YL, Cheong PY, Balakrishnan V. Singapore Med J; 1999 Jun; 40(6):405-9. PubMed ID: 10489509 [Abstract] [Full Text] [Related]
23. Complications of botulinum toxin a and their adverse effects. Rowe F, Noonan C. Strabismus; 2009 Jun; 17(4):139-42. PubMed ID: 20001507 [Abstract] [Full Text] [Related]
24. Long-term results of botulinum toxin-augmented medial rectus recessions for large-angle infantile esotropia. Lueder GT, Galli M, Tychsen L, Yildirim C, Pegado V. Am J Ophthalmol; 2012 Mar; 153(3):560-3. PubMed ID: 21996305 [Abstract] [Full Text] [Related]
25. The efficacy of vertical rectus transposition and its modalities in patients with abducens nerve palsy. Nowakowska O, Loba P, Broniarczyk-Loba A. Eur J Ophthalmol; 2011 Mar; 21(3):223-7. PubMed ID: 20853261 [Abstract] [Full Text] [Related]
26. The role of botulinum toxin in decompensated strabismus. Bansal S, Khan J, Marsh IB. Strabismus; 2008 Mar; 16(3):107-11. PubMed ID: 18788058 [Abstract] [Full Text] [Related]
27. Botulinum toxin in the management of acquired motor fusion deficiency. Murthy R, Kesarwani S. Indian J Ophthalmol; 2009 Mar; 57(6):463-4. PubMed ID: 19861751 [Abstract] [Full Text] [Related]
28. Role of Botulinum Toxin Type A in Cyclic Esotropia: A Long-Term Follow-up. Akyuz Unsal AI, Özkan SB, Ziylan S. J Pediatr Ophthalmol Strabismus; 2019 Nov 01; 56(6):360-364. PubMed ID: 31743403 [Abstract] [Full Text] [Related]
29. Clinical outcomes of botulinum toxin injection in patients with cerebral palsy and esotropia. Ameri A, Mirmohammadsadeghi A, Makateb A, Bazvand F, Hosseini S. Strabismus; 2015 Nov 01; 23(1):8-13. PubMed ID: 25789846 [Abstract] [Full Text] [Related]
30. Botulinum toxin injection with and without electromyographic assistance for treatment of abducens nerve palsy: a pilot study. Sanjari MS, Falavarjani KG, Kashkouli MB, Aghai GH, Nojomi M, Rostami H. J AAPOS; 2008 Jun 01; 12(3):259-62. PubMed ID: 18396081 [Abstract] [Full Text] [Related]
31. Botulinum toxin injection for restrictive myopathy of thyroid-associated orbitopathy: success rate and predictive factors. Akbari MR, Ameri A, Keshtkar Jaafari AR, Mirmohammadsadeghi A. J AAPOS; 2016 Apr 01; 20(2):126-130.e1. PubMed ID: 27079592 [Abstract] [Full Text] [Related]
32. The effect on quality of life of long-term botulinum toxin A injections to maintain ocular alignment in adult patients with strabismus. Hancox J, Sharma S, MacKenzie K, Adams G. Br J Ophthalmol; 2012 Jun 01; 96(6):838-40. PubMed ID: 22368263 [Abstract] [Full Text] [Related]
33. Botulinum toxin injection as primary treatment for esotropia in patients with cerebral palsy. Malgorzata M, Wojciech K, Alina BŁ, Artur B. Klin Oczna; 2013 Jun 01; 115(1):13-4. PubMed ID: 23882732 [Abstract] [Full Text] [Related]